Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Severe Gingivitis Associated with Ascorbic Acid-Deficiency in a Pediatric Patient.

Brand AJ, Lieberman MB, Hajishengallis E.

J Dent Child (Chic). 2019 May 15;86(2):125-128.

PMID:
31395119
2.

Complement-Dependent Mechanisms and Interventions in Periodontal Disease.

Hajishengallis G, Kajikawa T, Hajishengallis E, Maekawa T, Reis ES, Mastellos DC, Yancopoulou D, Hasturk H, Lambris JD.

Front Immunol. 2019 Mar 12;10:406. doi: 10.3389/fimmu.2019.00406. eCollection 2019. Review.

3.

Retrospective Analysis of Candida-related Conditions in Infancy and Early Childhood Caries.

Jean J, Goldberg S, Khare R, Bailey LC, Forrest CB, Hajishengallis E, Koo H.

Pediatr Dent. 2018 Mar 15;40(2):131-135.

4.

Candida albicans and Early Childhood Caries: A Systematic Review and Meta-Analysis.

Xiao J, Huang X, Alkhers N, Alzamil H, Alzoubi S, Wu TT, Castillo DA, Campbell F, Davis J, Herzog K, Billings R, Kopycka-Kedzierawski DT, Hajishengallis E, Koo H.

Caries Res. 2018;52(1-2):102-112. doi: 10.1159/000481833. Epub 2017 Dec 21.

5.

Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human Primates.

Kajikawa T, Briones RA, Resuello RRG, Tuplano JV, Reis ES, Hajishengallis E, Garcia CAG, Yancopoulou D, Lambris JD, Hajishengallis G.

Mol Ther Methods Clin Dev. 2017 Aug 18;6:207-215. doi: 10.1016/j.omtm.2017.08.001. eCollection 2017 Sep 15.

6.

Milk fat globule epidermal growth factor 8 inhibits periodontitis in non-human primates and its gingival crevicular fluid levels can differentiate periodontal health from disease in humans.

Kajikawa T, Meshikhes F, Maekawa T, Hajishengallis E, Hosur KB, Abe T, Moss K, Chavakis T, Hajishengallis G.

J Clin Periodontol. 2017 May;44(5):472-483. doi: 10.1111/jcpe.12707. Epub 2017 Apr 12.

7.

Oral literacy demand in the pediatric dental clinic: a pilot study.

Benadof D, Hajishengallis E, Cole A, Vidal C.

Int J Paediatr Dent. 2017 Sep;27(5):326-333. doi: 10.1111/ipd.12265. Epub 2016 Sep 9.

PMID:
27610600
8.

Early Childhood Caries: Future Perspectives in Risk Assessment.

Hajishengallis E, Forrest CB, Koo H.

JDR Clin Trans Res. 2016 Jul;1(2):110-111. doi: 10.1177/2380084416637577. Epub 2016 Mar 7. No abstract available.

9.

Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application.

Hajishengallis G, Hajishengallis E, Kajikawa T, Wang B, Yancopoulou D, Ricklin D, Lambris JD.

Semin Immunol. 2016 Jun;28(3):285-91. doi: 10.1016/j.smim.2016.03.006. Epub 2016 Mar 24. Review.

10.

Immune and regulatory functions of neutrophils in inflammatory bone loss.

Hajishengallis G, Moutsopoulos NM, Hajishengallis E, Chavakis T.

Semin Immunol. 2016 Apr;28(2):146-58. doi: 10.1016/j.smim.2016.02.002. Epub 2016 Feb 28. Review.

11.

Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3.

Maekawa T, Briones RA, Resuello RR, Tuplano JV, Hajishengallis E, Kajikawa T, Koutsogiannaki S, Garcia CA, Ricklin D, Lambris JD, Hajishengallis G.

J Clin Periodontol. 2016 Mar;43(3):238-49. doi: 10.1111/jcpe.12507. Epub 2016 Mar 3.

12.

Advances in the microbial etiology and pathogenesis of early childhood caries.

Hajishengallis E, Parsaei Y, Klein MI, Koo H.

Mol Oral Microbiol. 2017 Feb;32(1):24-34. doi: 10.1111/omi.12152. Epub 2016 Feb 4. Review.

13.

Autoimmune Neutropenia as a Cause of Periodontal Disease in Preschool Children.

Hajishengallis E, Rashewsky S, Kulkarni C, Stathopoulou P.

J Clin Pediatr Dent. 2016 Winter;40(1):69-75. doi: 10.17796/1053-4628-40.1.69.

PMID:
26696110
14.

DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates.

Shin J, Maekawa T, Abe T, Hajishengallis E, Hosur K, Pyaram K, Mitroulis I, Chavakis T, Hajishengallis G.

Sci Transl Med. 2015 Sep 30;7(307):307ra155. doi: 10.1126/scitranslmed.aac5380.

15.

Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.

Mastellos DC, Ricklin D, Hajishengallis E, Hajishengallis G, Lambris JD.

Mol Oral Microbiol. 2016 Feb;31(1):3-17. doi: 10.1111/omi.12129. Epub 2015 Oct 7. Review.

16.

Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches.

Hajishengallis G, Maekawa T, Abe T, Hajishengallis E, Lambris JD.

Adv Exp Med Biol. 2015;865:57-74. doi: 10.1007/978-3-319-18603-0_4. Review.

17.

Neutrophil homeostasis and inflammation: novel paradigms from studying periodontitis.

Hajishengallis G, Chavakis T, Hajishengallis E, Lambris JD.

J Leukoc Biol. 2015 Oct;98(4):539-48. doi: 10.1189/jlb.3VMR1014-468R. Epub 2014 Dec 29. Review.

18.

Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis.

Maekawa T, Abe T, Hajishengallis E, Hosur KB, DeAngelis RA, Ricklin D, Lambris JD, Hajishengallis G.

J Immunol. 2014 Jun 15;192(12):6020-7. doi: 10.4049/jimmunol.1400569. Epub 2014 May 7.

19.

Neutrophil homeostasis and periodontal health in children and adults.

Hajishengallis E, Hajishengallis G.

J Dent Res. 2014 Mar;93(3):231-7. doi: 10.1177/0022034513507956. Epub 2013 Oct 4. Review.

20.

Psychotropic drugs and their impact on the treatment of paediatric dental patients.

Hajishengallis E.

Eur Arch Paediatr Dent. 2013 Aug;14(4):197-206. doi: 10.1007/s40368-013-0053-4. Epub 2013 Jun 21.

PMID:
23794248
21.

Role of complement in host-microbe homeostasis of the periodontium.

Hajishengallis G, Abe T, Maekawa T, Hajishengallis E, Lambris JD.

Semin Immunol. 2013 Feb;25(1):65-72. doi: 10.1016/j.smim.2013.04.004. Epub 2013 May 16. Review.

22.

Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist.

Abe T, Hosur KB, Hajishengallis E, Reis ES, Ricklin D, Lambris JD, Hajishengallis G.

J Immunol. 2012 Dec 1;189(11):5442-8. doi: 10.4049/jimmunol.1202339. Epub 2012 Oct 22.

Supplemental Content

Loading ...
Support Center